Edition:
United Kingdom

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

15.78USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$15.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
161,315
52-wk High
$17.96
52-wk Low
$9.40

About

Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. It is focused on development of RNAi-based therapeutics using its GalXC RNAi... (more)

Overall

Beta: 2.16
Market Cap(Mil.): $1,022.81
Shares Outstanding(Mil.): 68.32
Dividend: --
Yield (%): --

Financials

  DRNA.OQ Industry Sector
P/E (TTM): -- 96.93 34.10
EPS (TTM): -1.70 -- --
ROI: -49.87 7.71 12.64
ROE: -74.34 8.16 17.18

Earnings vs. Estimates